- Home
- XPON vs VTAK Comparison
XPON vs VTAK Comparison
Compare XPON & VTAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XPON
- VTAK
- Stock Information
- Founded
- XPON 2016
- VTAK 2002
- Country
- XPON United States
- VTAK United States
- Employees
- XPON N/A
- VTAK N/A
- Industry
- XPON Electronic Components
- VTAK Medical/Dental Instruments
- Sector
- XPON Technology
- VTAK Health Care
- Exchange
- XPON Nasdaq
- VTAK Nasdaq
- Market Cap
- XPON 3.0M
- VTAK 3.1M
- IPO Year
- XPON 2022
- VTAK 2018
- Fundamental
- Price
- XPON $1.44
- VTAK $0.22
- Analyst Decision
- XPON
- VTAK
- Analyst Count
- XPON 0
- VTAK 0
- Target Price
- XPON N/A
- VTAK N/A
- AVG Volume (30 Days)
- XPON 3.0M
- VTAK 2.2M
- Earning Date
- XPON 08-13-2025
- VTAK 08-13-2025
- Dividend Yield
- XPON N/A
- VTAK N/A
- EPS Growth
- XPON N/A
- VTAK N/A
- EPS
- XPON N/A
- VTAK N/A
- Revenue
- XPON $6,702,411.00
- VTAK $481,000.00
- Revenue This Year
- XPON $61.26
- VTAK $822.86
- Revenue Next Year
- XPON N/A
- VTAK $168.42
- P/E Ratio
- XPON N/A
- VTAK N/A
- Revenue Growth
- XPON 23.07
- VTAK 9.57
- 52 Week Low
- XPON $0.60
- VTAK $0.16
- 52 Week High
- XPON $115.68
- VTAK $2.49
- Technical
- Relative Strength Index (RSI)
- XPON 69.98
- VTAK 43.37
- Support Level
- XPON $1.29
- VTAK $0.20
- Resistance Level
- XPON $1.77
- VTAK $0.24
- Average True Range (ATR)
- XPON 0.15
- VTAK 0.02
- MACD
- XPON 0.05
- VTAK 0.00
- Stochastic Oscillator
- XPON 64.13
- VTAK 31.50
About XPON Expion360 Inc.
Expion360 Inc is focused on the design, assembly, manufacturing, and sales of lithium iron phosphate (LiFePO4) batteries and supporting accessories for recreational vehicles (RV's) and marine applications with plans to expand into home energy storage products and industrial applications. Its product offerings include some of the minimal-footprint batteries in the RV & Marine industry.
About VTAK Catheter Precision Inc.
Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.